N6-methyladenosine (m6A) monoclonal antibody - Classic

Catalog Number
50 μg/ 25 μl
  Bulk order

Monoclonal antibody raised in mouse against N6-methyladenosine (m6A) conjugated to BSA.

Concentration2 μg/μl
Species reactivityHuman, mouse, other (wide range)
PurityProtein A purified
PrecautionsThis product is for research use only. Not for use in diagnostic or therapeutic procedures.
Applications Suggested dilution References
Dot Blotting 1:500 Fig 1, 2
RIP * 5 μg per IP Fig 3

* Please note that the optimal antibody amount per IP should be determined by the end-user. We recommend testing 1-10 μg per IP.

  • Validation Data

    Dot blot

    Figure 1. Dot blot analysis using the Diagenode monoclonal antibody directed against m6A
    To demonstrate the specificity of the Diagenode monoclonal antibody against m6A (Cat. No. C15200082), a Dot Blot analysis was performed using an m6A containing, a non-methylated control and a non-methylated polyA control synthetic RNA oligonucleotide.

    Dot blot

    Figure 2. Dot blot analysis using the Diagenode monoclonal antibody directed against m6A
    Dot Blot analysis was performed using a synthetic DNA oligonucleotide containing different m6A modified bases and a negative control. 100 to 4 pmol of the respective oligo’s were spotted on the membrane. The antibody was diluted of 1:500 in TBS-T containing 10 % skimmed milk and 1% BSA. Figure 1 shows a high specificity of the antibody for the modified oligonucleotide.


    Figure 3. RNA immunoprecipitation using the Diagenode monoclonal antibody directed against m6A
    Immunoprecipitation was performed on two radiolabelled synthetic DNA oligo’s, a 250 nt oligo containing m6A nucleotides and a 350 nt unmethylated control, using the Diagenode monoclonal m6A antibody (cat. nr. C15200082). The immunoprecipitated fraction is shown in lane 3; lane 2 shows the non bound fraction, whereas the input is shown in lane 1.

  • Target description

    N6-methyladenosine (m6A) is a modified base which is abundant in mRNA in most eukaryotes but also has been found in tRNA’s, rRNA’s, snRNA’s and in long non-coding RNA’s. Adenosine methylation is catalyzed by m6A methyltransferase, a large protein complex which has a preference for the consensus sequence GGACU. In human, the m6A modification has been identified in more than 7000 genes. It is preferably present around stop codons and in the 3’ UTR but has not been observed in poly A tails. m6A is dynamically regulated both throughout development and in response to cellular stimuli. Levels are significantly higher in adulthood than during embryonic development.

    Although the presence of m6A in RNA was identified several years ago, it’s physiological significance remains largely unknown. It has been proposed to affect mRNA processing and export from nucleus to cytoplasm. Recently, it was shown that mutations in the m6A demethylase gene FTO, which cause a decrease of m6A levels, are associated with an increased risk for obesity and type 2 diabetes.

  • Applications
    RIP Read more
    Dot blotting Read more
  • Documents
    m6A monoclonal antibody C15200082 DATASHEET
    Monoclonal antibody raised in mouse against N6-methyladenosine (m6A) conjugated to BSA.
    Antibodies you can trust POSTER
    Epigenetic research tools have evolved over time from endpoint PCR to qPCR to the analyses of lar...
    Epigenetic Antibodies Brochure BROCHURE
    More than in any other immuoprecipitation assays, quality antibodies are critical tools in many e...
  • Publications

    How to properly cite this product in your work

    Diagenode strongly recommends using this: N6-methyladenosine (m6A) monoclonal antibody - Classic (Diagenode Cat# C15200082 Lot# 001). Click here to copy to clipboard.

    Using our products in your publication? Let us know!


  • European Human Genetics Conference
    Copenhagen, Denmark
    May 27-May 30, 2017
 See all events

Twitter feed


 See all news